NGM·Healthcare·$1.1B·#74 / 520 in Healthcare
CDNA CareDx, Inc.
68SOLID
CATEGORY BREAKDOWN
GROWTH22
QUALITY70
STABILITY98
VALUATION92
GOVERNANCE52
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+13.8%
22
> 50% strong
Gross Margin
Revenue retained after direct costs
67.6%
96
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
8.6%
93
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.6x
92
< 3x strong
Rule of 40
Growth rate plus operating margin
7
31
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
3.4%
27
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-2.9%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CDNA WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CDNA's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.